SGLT inhibition in patients with type 1 diabetes

Lancet Diabetes Endocrinol. 2014 Jul;2(7):539. doi: 10.1016/S2213-8587(14)70112-3. Epub 2014 Jun 8.

Author

Clayton A Dehn¹

Affiliation

¹ Metabolic Diseases, Celerion, Tempe, AZ 85283, USA. Electronic address: [email protected].

PMID: 24920585
DOI: 10.1016/S2213-8587(14)70112-3

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 1 / drug therapy*
Humans
Hypoglycemic Agents / adverse effects*
Hypoglycemic Agents / therapeutic use
Sodium-Glucose Transport Proteins / antagonists & inhibitors*

Substances

Hypoglycemic Agents
Sodium-Glucose Transport Proteins